Our structure
Executive Board
Florence Baron-Papillon
President (Sanofi)
Juan Carlos Jaramillo
Vice-President & Treasurer (Valneva)
Andreas Potthoff
(Abbott)
Lorenzo Wittum
(AstraZeneca)
Sharon McHale
(CSL Seqirus)
Guillermo De Juan Echávarri
(GSK)
Lydia Ogden
(Johnson & Johnson)
Alexander Meier
(Moderna)
Nicoletta Luppi
(MSD)
Kelly Cappio
(Novavax)
Tobias Cousens
(Pfizer)
Executive Office
Sibila Quilici
Executive Director
Laurent Louette
Director Public Affairs & Country Liaison
Anna Czwarno
Director, Regulatory and R&D
Charlotte Vernhes
Director, Scientific and Medical Affairs
Anna Vicere
Associate Director, Public Affairs & Access Policy
Andreea Iordache
Manager Science & Regulatory Affairs
Polina Zoteva
Communications Lead
Anne Meynaerts
Administrative Assistant
Working Group Chairs
Public Affairs
Nilsy Desaint
MSD
Regulatory Affairs
Pascale Vintezou
Sanofi
RESEARCH, INNOVATION & MEDICAL
Jean Lang
Sanofi
Market Access
Kathleen Grieve
MSD
Manufacturing & Supply
Niko Salo
Pfizer
NATIONAL VACCINE INDUSTRY GROUP’S TASK FORCE
Gisela Payeras Bailly
GSK